Proportion of individuals without treatment failure over the 48 study weeks by randomization arm in the (a) per protocol population and (b) intention to treat population. Barbara Rossetti Roberta Gagliardini Genny Meini Gaetana Sterrantino Vincenzo Colangeli Maria Carla Re Alessandra Latini Manuela Colafigli Francesca Vignale Stefano Rusconi Valeria Micheli Antonio Di Biagio Giancarlo Orofino Valeria Ghisetti Alessandra Fantauzzi Vincenzo Vullo Pierfrancesco Grima Daniela Francisci Claudio Mastroianni Andrea Antinori Michele Trezzi Lucia Lisi Pierluigi Navarra Benedetta Canovari Antonella D’Arminio Monforte Silvia Lamonica Alessandro D’Avino Maurizio Zazzi Simona Di Giambenedetto Andrea De Luca 10.1371/journal.pone.0187393.g002 https://plos.figshare.com/articles/figure/Proportion_of_individuals_without_treatment_failure_over_the_48_study_weeks_by_randomization_arm_in_the_a_per_protocol_population_and_b_intention_to_treat_population_/5621905 <p>Arm S = study arm (switch to maraviroc + darunavir/ritonavir); Arm C = continuation arm (continuation of previous 3-drug therapy).</p> 2017-11-21 18:28:05 randomized trial Objectives 3- drug ART CCR 5-tropic virus plasma drug levels Femoral bone mineral density RNA virologically maraviroc week 48. Methods Patients continuation arm 3- drug therapy HIV treatment failure VF 48- week results 59 continuation arm study arm darunavir QD